{"id":"W4404435807","doi":"10.17615/d5s2-9s76","title":"Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis","year":2024,"lang":"en","type":"article","venue":"UNC Libraries","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Legend Biotech; bluebird bio; Alexion Pharmaceuticals; Pharmacyclics; Novavax; Adaptive Biotechnologies; Health Resources and Services Administration; Kite Pharma; Takeda Oncology; AstraZeneca; Genentech; MorphoSys; Syndax Pharmaceuticals; Seagen; CTI Biopharma; CareDx; BeiGene; Juno Therapeutics; Swedish Orphan Biovitrum; Astellas Pharma; Atara Biotherapeutics; Jazz Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; MEI Pharma; Omeros Corporation; Karyopharm Therapeutics; HistoGenetics; Gateway for Cancer Research; Celgene; Mallinckrodt Pharmaceuticals; Spectrum Pharmaceuticals; Actinium Pharmaceuticals; Gilead Sciences; TG Therapeutics; Sanofi; Kiadis Pharma; GlaxoSmithKline; aTyr; CSL Behring; Bristol-Myers Squibb; Eli Lilly and Company; Vertex Pharmaceuticals; Astellas Pharma US; Amgen; Novartis Pharmaceuticals Corporation; Incyte; Pfizer","keywords":"Chimeric antigen receptor; Lymphoma; Medicine; Immunology; B cell; Bone marrow; Antigen; T cell; Antibody; Immune system","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008320821,0.0001765218,0.0003686312,0.0009916693,0.0001480911,0.0002335401,0.0002055755,0.0001308872,0.001594134],"category_scores_gemma":[0.000131326,0.000145155,0.0002136552,0.0009702615,0.0001123408,0.0002401453,0.0001124489,0.0002140861,0.00001106459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005932766,"about_ca_system_score_gemma":0.0002435583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003980395,"about_ca_topic_score_gemma":0.00002721507,"domain_scores_codex":[0.9980062,0.0001030136,0.000348544,0.0005205729,0.0005181501,0.000503467],"domain_scores_gemma":[0.998666,0.0006603784,0.00003212721,0.0002555547,0.0002107985,0.0001751669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.009633937,0.003560631,0.1317645,0.003164725,0.002034906,0.0001727329,0.009747966,0.000003640265,0.7617111,0.009712086,0.05072838,0.0177654],"study_design_scores_gemma":[0.01421635,0.0007640079,0.003789354,0.0004566738,0.0002732632,0.00001483691,0.000532996,0.0117287,0.08738071,0.00207083,0.8784693,0.0003029377],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9715971,0.007133452,0.002294805,0.005841644,0.0007119242,0.00276977,0.001818376,0.0001610375,0.007671911],"genre_scores_gemma":[0.9382299,0.001360672,0.0155255,0.0003706678,0.0009876433,0.0003652571,0.003424653,0.0001217314,0.03961405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.827741,"threshold_uncertainty_score":0.9993185,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0441716723019166,"score_gpt":0.3254826321958296,"score_spread":0.281310959893913,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}